Clinical Trial

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if neoadjuvant therapy to increases resection rate for pancreatic adenocarcinoma.
Protocol Amendment History 1 change
minor Completion pushed: 2026-06-01 -> 2027-06-01 2026-08-12
Trial Details
NCT Number NCT04594772
Lead Sponsor University of Cincinnati
Conditions Pancreas Cancer
Enrollment 32 participants
Start Date 2021-03-17
Primary Completion 2025-06-13 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11